peripheral blood polymorphonuclear neutrophils in nonhuman primates Recombinant human GM-CSF induces leukocytosis and activates

[1]  Yuji Togashi,et al.  Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2 , 2004, Cancer Immunology, Immunotherapy.

[2]  S. Rosenberg,et al.  Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2. , 1986, Cancer research.

[3]  J. Adamson,et al.  Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[4]  A. Mufson,et al.  Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin. , 1986, The Journal of clinical investigation.

[5]  P. Sehgal,et al.  Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF , 1986, Nature.

[6]  R. Donahue,et al.  Human recombinant granulocyte-macrophage colony-stimulating factor: a multilineage hematopoietin. , 1985, Science.

[7]  R. Donahue,et al.  Demonstration of burst-promoting activity of recombinant human GM-CSF on circulating erythroid progenitors using an assay involving the delayed addition of erythropoietin. , 1985, Blood.

[8]  S. Clark,et al.  Purification of fetal hematopoietic progenitors and demonstration of recombinant multipotential colony-stimulating activity. , 1985, The Journal of clinical investigation.

[9]  E. Brown,et al.  Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. , 1985, Science.

[10]  Stanley Er,et al.  Factors affecting the growth and differentiation of haemopoietic cells in culture. , 1984 .

[11]  J. Griffin,et al.  Induction of proliferation of purified human myeloid progenitor cells: a rapid assay for granulocyte colony-stimulating factors. , 1984, Blood.

[12]  Z. Madar,et al.  The kidney is the main site of interferon degradation. , 1982, Journal of interferon research.

[13]  Kendall A. Smith,et al.  Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. , 1981, Molecular immunology.

[14]  R. Willemze,et al.  Marrow culture in diffusion chambers in rabbits. I. Effect of mature granulocytes on cell production. , 1978, Blood.

[15]  J. Hickman,et al.  Role of the carbohydrate moiety in determining the survival of interferon in the circulation. , 1977, The Journal of biological chemistry.

[16]  P. Ralph,et al.  Cell-free granulocyte colony inhibiting activity derived from human polymorphonuclear neutrophils. , 1977, Experimental hematology.

[17]  H. Broxmeyer,et al.  Control of granulopoiesis in man. III. Inhibition of colony formation by dense leukocytes , 1975, Journal of cellular physiology.

[18]  A. Morley,et al.  Computer simulation of granulopoiesis: normal and impaired granulopoiesis. , 1970, Blood.

[19]  A. Morley,et al.  Cyclophosphamide-induced cyclical neutropenia. An animal model of a human periodic disease. , 1970, The New England journal of medicine.

[20]  G. Cartwright,et al.  Neutrophil kinetics in acute infection. , 1967, The Journal of clinical investigation.